Princeton Global Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Princeton Global Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.2K	Hold	80	–	–	﹤0.01%	529
2026 Q1	$13.5K	Hold	80	–	–	﹤0.01%	540
2025 Q4	$13.5K	Sell	80 -300	-79%	-$48.7K	﹤0.01%	542
2025 Q3	$54.9K	Buy	380 +300	+375%	+$41K	0.01%	310
2025 Q2	$10.1K	Hold	80	–	–	﹤0.01%	525
2025 Q1	$10.2K	Hold	80	–	–	﹤0.01%	456
2024 Q4	$10.6K	Sell	80 -10	-11%	-$1.41K	﹤0.01%	488
2024 Q3	$13.1K	Sell	90 -1,617	-95%	-$234K	﹤0.01%	469
2024 Q2	$234K	Hold	1,707	–	–	0.05%	155
2024 Q1	$234K	Buy	1,707 +107	+7%	+$14.6K	0.06%	150
2023 Q4	$217K	Hold	1,600	–	–	0.05%	157
2023 Q3	$196K	Hold	1,600	–	–	0.06%	158
2023 Q2	$203K	Sell	1,600 -1,765	-52%	-$229K	0.06%	159
2023 Q1	$435K	Sell	3,365 -405	-11%	-$53K	0.13%	112
2022 Q4	$495K	Hold	3,770	–	–	0.16%	105
2022 Q3	$441K	Hold	3,770	–	–	0.15%	106
2022 Q2	$443K	Sell	3,770 -1,150	-23%	-$137K	0.14%	113
2022 Q1	$641K	Sell	4,920 -350	-7%	-$45.6K	0.18%	103
2021 Q4	$804K	Hold	5,270	–	–	0.23%	103
2021 Q3	$852K	Hold	5,270	–	–	0.26%	95
2021 Q2	$862K	Hold	5,270	–	–	0.26%	93
2021 Q1	$793K	Hold	5,270	–	–	0.26%	98
2020 Q4	$798K	Hold	5,270	–	–	0.28%	96
2020 Q3	$714K	Sell	5,270 -940	-15%	-$128K	0.29%	94
2020 Q2	$848K	Hold	6,210	–	–	0.26%	108
2020 Q1	$669K	Buy	6,210 +895	+17%	+$103K	0.3%	99
2019 Q4	$641K	Buy	5,315 +540	+11%	+$60.2K	0.26%	98
2019 Q3	$468K	Hold	4,775	–	–	0.27%	102
2019 Q2	$521K	Hold	4,775	–	–	0.31%	91
2019 Q1	$533K	Hold	4,775	–	–	0.37%	78
2018 Q4	$460K	Buy	+4,775	New	+$507K	0.41%	71

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Princeton Global Asset Management's IBB Position: Q2 2026 in Review

Princeton Global Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 80 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #529.

Princeton Global Asset Management first reported a position in IBB in Q4 2018 and has held it in 31 quarters since. The position peaked at $862K in Q2 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Princeton Global Asset Management held 80 shares of iShares Biotechnology ETF worth $15.2K as of Q2 2026.
Princeton Global Asset Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #529 holding.
Princeton Global Asset Management first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 31 quarters since.
Princeton Global Asset Management's iShares Biotechnology ETF position peaked at $862K in Q2 2021.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.